ArticleMedComm2025
Preclinical Characterization of SDFZ-8, a Highly Potent HDAC1 Inhibitor, for Cancer Immunotherapy.
Yi Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleMedComm2025
Yi Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.